Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2969841 | The Journal of Heart and Lung Transplantation | 2015 | 7 Pages |
Abstract
MS use at 30 days post-transplant was not associated with enhanced graft survival after pediatric heart transplant. MSâ patients had a higher incidence of RSHC and infection. These risks should be taken into consideration when determining MS use for pediatric recipients of heart transplants.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Scott R. MD, Manisha MD, MPH, Deborah CPNP, Heather CPNP, Brian MD, Kenneth MD, Beth D. MD, Robert N. BS, Shelley D. MD,